Regulation of MHC Class II Expression by Interferon-γ Mediated by the Transactivator Gene CIITA
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Major histocompatibility complex (MHC) class II genes are expressed constitutively in only a few cell types, but they can be induced in the majority of them, in particular by interferon-gamma (IFN-gamma). The MHC class II transactivator gene CIITA is defective in a form of primary MHC class II deficiency. Here it is shown that CIITA expression is controlled and induced by IFN-gamma. A functional CIITA gene is necessary for class II induction, and transfection of CIITA is sufficient to activate expression of MHC class II genes in class II-negative cells in the absence of IFN-gamma. CIITA is therefore a general regulator of both inducible and constitutive MHC class II expression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The expression of PD-L1 and MHC II, which may cause exhaustion by binding to T-cell programmed cell death protein 1 (PD-1) and lymphocyte activation gene 3 (LAG-3), respectively, is regulated by tumor interferon (IFN) signaling.”
From Tumor interferon signaling and suppressive myeloid cells are associated with CAR T-cell failure in large B-cell lymphoma (2021) · cites this paper as [27]
Citations
Cites
Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.
Gorman, C. M., Moffat, L. F., & Howard, B. H. (1982) · Molecular and Cellular Biology · doi:10.1128/mcb.2.9.1044 · Cited by 7,830
Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor
Schindler, C., Shuai, K., Prezioso, V. R., & Darnell, J. E. (1992) · Science · doi:10.1126/science.1496401 · Cited by 899
Steimle, V (1993) · Cell · doi:10.1016/0092-8674(93)90685-j · Cited by 864
A Single Phosphotyrosine Residue of Stat91 Required for Gene Activation by Interferon-γ
Shuai, K., Stark, G. R., Kerr, L. M., & Darnell, J. E. (1993) · Science · doi:10.1126/science.7690989 · Cited by 802
Activation of Transcription by IFN-γ: Tyrosine Phosphorylation of a 91-kD DNA Binding Protein
Shuai, K., Schindler, C., Prezioso, V. R., & Darnell, J. E. (1992) · Science · doi:10.1126/science.1281555 · Cited by 775
Collins, T., Korman, A. J., Wake, C. T., Boss, J. M., Kappes, D. J., Fiers, W., Ault, K. A., Gimbrone, M. A., Strominger, J. L., & Pober, J. S. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.15.4917 · Cited by 585
Sequences And Factors: A Guide To Mhc Class-Ii Transcription
Glimcher, L. (1992) · Annual Review of Immunology · doi:10.1146/annurev.immunol.10.1.13 · Cited by 534
Benoist, C., & Mathis, D. (1990) · Annual Review of Immunology · doi:10.1146/annurev.iy.08.040190.003341 · Cited by 457
Müller, M., Laxton, C., Briscoe, J., Schindler, C., Improta, T., Darnell, J. E., Stark, G. R., & Kerr, I. M. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06106.x · Cited by 411
Detection of a novel human class II HLA antigen
Watson, A. J., DeMars, R., Trowbridge, I. S., & Bach, F. H. (1983) · Nature · doi:10.1038/304358a0 · Cited by 376
Cited by
Items 501–600 of 899
The Non‐Expression of MHC Class II in Trophoblast Cells
Mattsson, R. (1998) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.1998.tb00422.x · Cited by 20
Boe, D. M., Hulsebus, H. J., Najarro, K. M., Mullen, J. E., Kim, H., Tan, A. C., McMahan, R. H., & Kovacs, E. J. (2022) · Journal of Leukocyte Biology · doi:10.1002/jlb.3hi0620-399rr · Cited by 20
Jou, E. (2023) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2023.00146 · Cited by 23
mAb therapy controls CNS‐resident lyssavirus infection via a CD4 T cell‐dependent mechanism
Mastraccio, K. E., Huaman, C., Coggins, S. A., Clouse, C., Rader, M., Yan, L., Mandal, P., Hussain, I., Ahmed, A. E., Ho, T., et al. (2023) · EMBO Molecular Medicine · doi:10.15252/emmm.202216394 · Cited by 21
Butler, L. M., Jeffery, H. C., Wheat, R. L., Long, H. M., Rae, P. C., Nash, G. B., & Blackbourn, D. J. (2012) · Journal of Virology · doi:10.1128/jvi.06908-11 · Cited by 19
Srivastava, M. K., Bosch, J. J., Wilson, A. L., Edelman, M. J., & Ostrand‐Rosenberg, S. (2010) · International Journal of Cancer · doi:10.1002/ijc.25462 · Cited by 19
Shi, B., Thomas, A. J., Benninghoff, A. D., Sessions, B. R., Meng, Q., Parasar, P., Rutigliano, H. M., White, K. L., & Davies, C. J. (2017) · American Journal of Reproductive Immunology · doi:10.1111/aji.12779 · Cited by 20
Denniston, A. K., Tomlins, P. J., Williams, G. P., Kottoor, S. H., Khan, I. J., Oswal, K. S., Salmon, M., Wallace, G. R., Rauz, S., Murray, P. I., et al. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-8802 · Cited by 21
“To identify the mechanism by which uveitis AqH–induced upregulation of class I MHC, we investigated the role of a number of molecules that had previously been noted to be elevated in active uveitis, notably IFN and IL-6(25,26); additionally, IFN is known to be capable of MHC upregulation.(30) We therefore tested the e…”
BackgroundSanderson, I. R., Bustin, S. A., Dziennis, S., Paraszczuk, J., & Stamm, D. S. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.04.014 · Cited by 19
Santos, A. N. (1998) · International Immunology · doi:10.1093/intimm/10.5.601 · Cited by 19
Chornoguz, O., Gapeev, A., O’Neill, M. C., & Ostrand‐Rosenberg, S. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m112.019232 · Cited by 20
Role of antigen presentation in the production of pro-inflammatory cytokines in obese adipose tissue
Majdoubi, A., Kishta, O. A., & Thibodeau, J. (2016) · Cytokine · doi:10.1016/j.cyto.2016.01.023 · Cited by 21
T cell expression of CIITA represses Th1 immunity
Park, W. S. (2004) · International Immunology · doi:10.1093/intimm/dxh132 · Cited by 19
“Major histocompatibility complex class II transactivator (CIITA) is initially identified as a factor responsible for bare lymphocyte syndrome (1) and is now considered as a critical transactivatorrequiredfortheexpressionofMHCclassIIgenes in both conventional and non-conventional antigen-presenting cells(APCs)(2, 3 ).U…”
BackgroundMajor Histocompatibility Complex Class II Deficiency: A Disease of Gene Regulation
Steimle, V., Reith, W., & Mach, B. (1996) · Advances in immunology · doi:10.1016/s0065-2776(08)60870-6 · Cited by 19
Kuchtey, J., Pennini, M. E., Pai, R. K., & Harding, C. V. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.5.2320 · Cited by 19
“Transcriptional regulation of MHC-II is mediated by class II transactivator (CIITA), a transcriptional coactivator essential for both constitutive and IFN- -regulated expression of MHC-II (3).”
BackgroundMHC Class II Regulation — Lessons from a Disease
Mach, B. (1995) · New England Journal of Medicine · doi:10.1056/nejm199501123320211 · Cited by 19
The impact of sex and physical activity on the local immune response to muscle pain
Lesnak, J. B., Hayashi, K., Plumb, A. N., Janowski, A. J., Chimenti, M. S., & Sluka, K. A. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.03.020 · Cited by 22
Human CD4 cytotoxic T lymphocytes mediate potent tumor control in humanized immune system mice
Lin, W., Singh, V. J., Springer, R., Choonoo, G., Gupta, N., Patel, A. K., Frleta, D., Zhong, J., Owczarek, T. B., Decker, C. E., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-04812-3 · Cited by 21
Insight into Cancer Immunity: MHCs, Immune Cells and Commensal Microbiota
Wen, M., Li, Y., Qin, X., Qin, B., & Wang, Q. A. (2023) · Cells · doi:10.3390/cells12141882 · Cited by 21
Zecher, B. F., Ellinghaus, D., Schloer, S., Niehrs, A., Padoan, B., Baumdick, M. E., Yuki, Y., Martin, M. P., Głów, D., Schröder‐Schwarz, J., et al. (2023) · Gut · doi:10.1136/gutjnl-2023-329524 · Cited by 24
Novel Mechanisms of Class II Major Histocompatibility Complex Gene Regulation
Radosevich, M., & Ono, S. J. (2003) · Immunologic Research · doi:10.1385/ir:27:1:85 · Cited by 20
Function and Regulation of Class II Transactivator in the Immune System
Chang, C., Gourley, T. S., & Sisk, T. J. (2002) · Immunologic Research · doi:10.1385/ir:25:2:131 · Cited by 18
Lin, H., Thacore, H. R., Davis, F. B., Martino, L. J., & Davis, P. J. (1996) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1996.16.17 · Cited by 16
Banu, N., & Meyers, C. M. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00645.x · Cited by 19
Tai, A., Zhou, G., Chau, K., & Ono, S. J. (1999) · Molecular Immunology · doi:10.1016/s0161-5890(99)00061-9 · Cited by 17
Muczynski, K. A., Anderson, S. K., & Pious, D. A. (1998) · PubMed · Cited by 18
Stopeck, A., Vahedian, M., & Williams, S. K. (1997) · Cell Transplantation · doi:10.1016/s0963-6897(96)00183-2 · Cited by 18
Regulation of Class II Expression in Monocytic Cells after HIV-1 Infection
Rakoff-Nahoum, S., Chen, H., Kraus, T., George, I., Oei, E. J., Tyorkin, M., Salik, E., Beuria, P., & Sperber, K. E. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.4.2331 · Cited by 18
“Although RFX-5-, hX-2BP-, NF-YA-, and NF-YB-binding proteins are ubiquitously expressed, CIITA expression is restricted to class IIpositive cells (63, 64).”
BackgroundRetractedInnate Lymphoid Cells in Response to Intracellular Pathogens: Protection Versus Immunopathology
Korchagina, A. A., Koroleva, E. P., & Tumanov, A. V. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.775554 · Cited by 23
“IFNg secreted at early stages of infection enhances antigen presentation by antigen-presenting cells (APCs), such as macrophages and dendritic cells, by inducing MHC expression (Amaldi et al., 1989; Steimle et al., 1994; Xaus et al., 2000; Schroder et al., 2004).”
Backgroundde Biase, M. S., Massip, F., Wei, T., Giorgi, F. M., Stark, R., Stone, A., Gladwell, A., O’Reilly, M., Schütte, D., de Santiago, I., et al. (2024) · Genome Medicine · doi:10.1186/s13073-024-01317-4 · Cited by 22
Tollip-induced down-regulation of MARCH1
Bourgeois‐Daigneault, M., Pezeshki, A. M., Galbas, T., Houde, M., Baril, M., Früh, K., Amrani, A., Ishido, S., Lamarre, D., & Thibodeau, J. (2013) · Results in Immunology · doi:10.1016/j.rinim.2013.02.002 · Cited by 17
“[32] Steimle V, Siegrist C, Mottet A, Lisowska-Grospierre B, Mach B.”
Xu, Y., Ravid, K., & Smith, B. D. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708657200 · Cited by 17
GTP-dependent Recruitment of CIITA to the Class II Major Histocompatibility Complex Promoter
Bewry, N. N., Bolick, S. C. E., Wright, K. L., & Harton, J. A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611747200 · Cited by 17
Common distal elements orchestrate CIITA isoform-specific expression in multiple cell types
Lohsen, S., Majumder, P., Scharer, C. D., Barwick, B. G., Austin, J. W., Zinzow-Kramer, W. M., & Boss, J. M. (2014) · Genes and Immunity · doi:10.1038/gene.2014.49 · Cited by 19
Pisapia, L., Cicatiello, V., Barba, P., Malanga, D., Maffei, A., Hamilton, R. S., & Pozzo, G. D. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt059 · Cited by 18
“Non-professional APCs are non–bone marrow-derived cells that constitutively express MHCII molecules but do not have a complete range of co-stimulatory molecules, such as thymic epithelial cells (3) and endothelial cells in various organs, as well as cell types that do not have basal levels of MHCII molecules but can b…”
BackgroundThe Role of Autoimmunity-Related Gene CLEC16A in the B Cell Receptor–Mediated HLA Class II Pathway
Rijvers, L., Melief, M., van Langelaar, J., de Vries, R. M. V. D. V., Wierenga‐Wolf, A. F., Koetzier, S. C., Priatel, J. J., Jorritsma, T., van Ham, S. M., Hintzen, R. Q., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1901409 · Cited by 17
Prolonged MHC class II expression and CIITA transcription in human keratinocytes
Takagi, A., Nishiyama, C., Kanada, S., Niwa, Y., Fukuyama, K., Ikeda, S., Okumura, K., & Ogawa, H. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.05.215 · Cited by 17
Comparison of the transcriptional regulation of classical and non‐classical MHC class II genes
Hake, S. B., Tobin, H. M., Steimle, V., & Denzin, L. K. (2003) · European Journal of Immunology · doi:10.1002/eji.200323795 · Cited by 17
Isoforms of the class II transactivator protein
Barbieri, G. (2002) · International Immunology · doi:10.1093/intimm/dxf060 · Cited by 17
“In agreement with the appearance of the CIITA protein 2 h after IFN-g addition, and in contrast with a previous publication ( 23 ), MHC2TA transcripts were detected by RT-PCR as early Isoforms of the CIITA protein 841”
BackgroundMethodResultInfluentialMuczynski, K. A., Anderson, S. K., & Pious, D. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.7.3207 · Cited by 17
Krzak, M., Alegbe, T., Taylor, D., Ghouraba, M., Strickland, M., Satti, R., Thompson, T., Arestang, K., Przybilla, M., Ramirez-Navarro, L., et al. (2023) · medRxiv · doi:10.1101/2023.09.06.23295056 · Cited by 3
“MHC-II expression is classically restricted to professional antigen-presenting cells (pAPC) under the control of the CIITA master transactivator (Steimle et al. 1994).”
Interferon-γ causes myogenic cell dysfunction and senescence in immune myopathies
Hou, C., Periou, B., Gervais, M., Martin, L., Berthier, J., Baba‐Amer, Y., Souvannanorath, S., Lechapt, E., Malfatti, E., Gherardi, R. K., et al. (2025) · Brain · doi:10.1093/brain/awaf153 · Cited by 19
Expression and in vitro upregulation of MHCII in koala lymphocytes
Lau, Q., Canfield, P. J., & Higgins, D. P. (2012) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2012.04.010 · Cited by 16
Emerging Major Histocompatibility Complex Class I-Related Functions of NLRC5
Chelbi, S. T., Dang, A. T., & Guarda, G. (2017) · Advances in immunology · doi:10.1016/bs.ai.2016.11.003 · Cited by 19
Roerden, M., Märklin, M., Salih, H. R., Bethge, W. A., Klein, R., Rammensee, H., Nelde, A., & Walz, J. S. (2021) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2021.1885659 · Cited by 19
Burdett, N. L., Willis, M. O., Pandey, A., Twomey, L., Alaei, S., Australian Ovarian Cancer Study Group, Management Group, Bowtell, D. D. L., Chenevix‐Trench, G., Green, A. C., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50137-y · Cited by 24
“This is a topic which has been studied extensively in other tumour types 26,30,32,47 .”
InfluentialKim, A., Lee, K., Kwon, Y., Lee, K.-I., Yang, H.-M., Habib, O., Kim, J., Kim, S. J., Kim, J., Kim, J., et al. (2020) · Stem Cell Reviews and Reports · doi:10.1007/s12015-020-10113-7 · Cited by 17
Skewed fate and hematopoiesis of CD34+ HSPCs in umbilical cord blood amid the COVID-19 pandemic
Estep, B. K., Kuhlmann, C. J., Osuka, S., Suryawanshi, G. W., Nagaoka-Kamata, Y., Samuel, C. N., Blucas, M. T., Jepson, C. E., Goepfert, P., & Kamata, M. (2022) · iScience · doi:10.1016/j.isci.2022.105544 · Cited by 15
“53,54 Importantly, IFN-g disrupts quiescence of HSPCs and promotes excessive terminal differentiation via bone marrow stromal cell antigen 2 (BST2) that mediates HSPC delocalization and activation.”
Matheux, F., İkincioğulları, A., Zapata, D. A., Barras, E., Zufferey, M., Doğu, F., Regueiro, J. R., Reith, W., & Villard, J. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0804 · Cited by 16
The pilot study of anti-tumor effects versus immunosuppression of staphylococcal enterotoxin C
Jie, K.-G., Jiang, H., Sun, L., Wang, H., Zheng, Y., Jiang, Y., & Li, Y. (2007) · Cancer Biology & Therapy · doi:10.4161/cbt.6.10.4724 · Cited by 16
Rogers, K. A., & Titus, R. G. (2004) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2004.71.568 · Cited by 16
Tumor-specific CD4+ T cells eradicate myeloma cells genetically deficient in MHC class II display
Tveita, A. A., Fauskanger, M., Bogen, B., & Haabeth, O. A. W. (2016) · Oncotarget · doi:10.18632/oncotarget.11946 · Cited by 17
Steimle, V., & Mach, B. (1995) · Current Opinion in Genetics & Development · doi:10.1016/0959-437x(95)80034-4 · Cited by 16
Ramassar, V., Goes, N. B., HOBART, M. G., & Halloran, P. F. (1996) · Transplantation · doi:10.1097/00007890-199612270-00038 · Cited by 16
Itoh, T., Horiuchi, M., & Itoh, A. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.04.021 · Cited by 16
Tanno, L., Naheed, S., Dunbar, J., Tod, J., Lopez, M. A., Taylor, J., Machado, M., Green, B., Ashton‐Key, M., Chee, S., et al. (2021) · Neuroendocrinology · doi:10.1159/000517688 · Cited by 17
CARD-only proteins regulate in vivo inflammasome responses and ameliorate gout
Devi, S., Indramohan, M., Jäger, E. J., Carrière, J., Chu, L. H., de Almeida, L., Greaves, D. R., Stehlik, C., & Dorfleutner, A. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112265 · Cited by 18
Mumphrey, M. B., Hosseini, N., Parolia, A., Geng, J., Zou, W., Raghavan, M., Chinnaiyan, A. M., & Cieslik, M. P. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112965 · Cited by 16
Masad, R. J., Idriss, I., Mohamed, Y. A., Al-Sbiei, A., Bashir, G. H., Al-Marzooq, F. I., Altahrawi, A., Fernández-Cabezudo, M. J., & al-Ramadi, B. K. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1354297 · Cited by 15
Sun, T., Ferrero, R. L., Girardin, S. E., Gommerman, J. L., & Philpott, D. J. (2019) · Immunology and Cell Biology · doi:10.1111/imcb.12244 · Cited by 17
“The major histocompatibility complex (MHC) class II transactivator (CIITA) is an NLR family member that shuttles between the nucleus and the cytosol to regulate the expression of MHC-II.(2,3) Similar to CIITA, the NOD-like receptor (NLR) caspase activation and recruitment domain CARD containing 5 (NLRC5) (also known a…”
BackgroundLiu, J., Yang, L., Liu, F., Li, H., Tang, W., Tong, X., & Zuo, J. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.05.083 · Cited by 17
Wang, H., Zhao, S., Zhang, X., Jia, K., Deng, J., Zhou, C., & He, Y. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s214231 · Cited by 15
“It has been demonstrated that MHC class II expression induced by IFN-γ was mediated by CIITA.(58) TGF-β suppressed MHC class II induced by IFN-γ also through restricting CIITAmRNA accumulation.”
BackgroundFueldner, C., Riemschneider, S., Haupt, J., Jungnickel, H., Schulze, F., Zoldan, K., Esser, C., Hauschildt, S., Knauer, J., Luch, A., et al. (2022) · Cells · doi:10.3390/cells11040737 · Cited by 16
“MHC-II expression is induced by IFN-γ via the MHC class II transactivator CIITA [45] or via the NF-κB subunit RelB [46].”
BackgroundSaikh, K. U., Kissner, T. L., & Ulrich, R. G. (2002) · Immunology · doi:10.1046/j.1365-2567.2002.01446.x · Cited by 15
Aitken, R. J., Fisher, H. M., Fulton, N., Gomez, E., Knox, W., Lewis, B., & Irvine, S. (1997) · Molecular Reproduction and Development · doi:10.1002/(sici)1098-2795(199708)47:4<468::aid-mrd14>3.0.co;2-s · Cited by 305
Liu, Y., Meng, Y., Wang, Q., & Sha, Z. (2012) · Molecular Biology Reports · doi:10.1007/s11033-012-2007-z · Cited by 16
A Novel Transactivating Factor That Regulates Interferon-γ-dependent Gene Expression
Hu, J., Meng, Q., Roy, S. K., Raha, A., Hu, J., Zhang, J., Hashimoto, K., & Kalvakolanu, D. V. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202679200 · Cited by 20
Kanazawa, S., & Peterlin, B. M. (2001) · International Immunology · doi:10.1093/intimm/13.7.951 · Cited by 15
LI, Y., KOSTER, T., Mörike, C., VHORSTEN, S., Martin, U., Bäder, M., Haverich, A., & SIMON, A. (2006) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2006.03.072 · Cited by 15
“Themechanism of this inhibition is a result of reduced activation of the inducible promoter IV on the transactivator CIITA [10,11] and has been observed in a variety of cells [10].”
BackgroundGustafsson, E., Arvola, M., Brunsberg, U., Mattsson, A., & Mattsson, R. (1997) · Biology of Reproduction · doi:10.1095/biolreprod57.4.715 · Cited by 15
Czaja, A. J. (2023) · Digestive Diseases and Sciences · doi:10.1007/s10620-023-07967-5 · Cited by 19
“Conducive microenvironment Pro-inflammatory IFN-γ induces class II MHC molecules by CIITA gene [93–95] Bystander response [21, 140, 141] Release of neo-antigens [127] Expands number and variety of APCs [93] Increases activated CD4+ T cells [93] Promotes epitope spread [137–139]”
BackgroundInfluentialFujiwara, H., Ochi, T., Ochi, F., Miyazaki, Y., Asai, H., Narita, M., Okamoto, S., Mineno, J., Kuzushima, K., Shiku, H., et al. (2015) · Leukemia · doi:10.1038/leu.2015.155 · Cited by 14
Prod’homme, T., Dekel, B., Barbieri, G., Lisowska‐Grospierre, B., Katz, R., Charron, D. J., Alcaïde‐Loridan, C., & Pollack, S. (2003) · Immunogenetics · doi:10.1007/s00251-003-0609-2 · Cited by 14
“Most importantly, CIITA is the key molecule controlling the tissue-specific expression pattern of the MHC class II genes (Steimle et al. 1994).”
BackgroundSiciliano, N. A., Hersperger, A. R., Lacuanan, A., Xu, R.-H., Sidney, J., Sette, A., Sigal, L. J., & Eisenlohr, L. C. (2014) · Journal of Virology · doi:10.1128/jvi.01150-14 · Cited by 14
Overexpression of CIITA in T Cells Aggravates Th2-Mediated Colitis in Mice
Kim, T. W., Park, H. J., Choi, E. Y., & Jung, K. C. (2006) · Journal of Korean Medical Science · doi:10.3346/jkms.2006.21.5.877 · Cited by 14
“Besides its function as a key regulator for the expression of MHC class II molecule (1, 2), CIITA has been known to play additional roles in Th differentiation and activation-induced cell death (8, 9, 12, 14, 18).”
BackgroundYin, J., Zheng, J., Deng, F., Zhao, W., Chen, Y., Huang, Q., Huang, R., Wen, L., Yue, X., Petersen, F., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02362 · Cited by 14
“Moreover, it has been reported that IFN-γ regulate the expression of MHC II by acting on IRF-1 and CIITA (19).”
BackgroundInfluentialChan, J. N. E., Humphry, M., Kitt, L., Krzyzanska, D., Filbey, K. J., Bennett, M. R., & Clarke, M. C. H. (2020) · European Journal of Immunology · doi:10.1002/eji.201948521 · Cited by 17
Santos, A. N., Riemann, D., Thiele, K., Kehlen, A., Santos, A. N., & Langner, J. (1997) · Immunology Letters · doi:10.1016/s0165-2478(97)02712-0 · Cited by 14
Lee, P. T., Holt, P. G., & McWilliam, A. S. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200108)31:8<2347::aid-immu2347>3.0.co;2-z · Cited by 15
Effect of transforming growth factor-β1 on microglial MHC-class II expression
Pázmány, T., Kosa, J. P., Tomasi, T. B., Mechtler, L. L., Turoczı, A., & Lehotzky, A. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00169-1 · Cited by 14
Sepp, T., & Tong-Starksen, S. (1997) · Journal of Virology · doi:10.1128/jvi.71.1.771-777.1997 · Cited by 14
Hillman, G. G., Xu, M., Wang, Y., Wright, J. L., Lu, X., Kallinteris, N. L., Tekyi‐Mensah, S., Thompson, T. C., Mitchell, M. S., & Forman, J. D. (2003) · Human Gene Therapy · doi:10.1089/104303403765255156 · Cited by 15
Boss, J. M. (1999) · Microbes and Infection · doi:10.1016/s1286-4579(99)00234-8 · Cited by 14
CD4+ cytotoxic T cells: an emerging effector arm of anti-tumor immunity
Jeong, S., Jang, N., Kim, M., & Choi, I. (2023) · BMB Reports · doi:10.5483/bmbrep.2023-0014 · Cited by 16
“Although MHC-II antigen presentation is known to be induced by IFN-γ in some tumor cells (57, 58), mechanisms for its induction and regulation in tumor cells largely remain unknown.”
DUX4 is a common driver of immune evasion and immunotherapy failure in metastatic cancers
Pineda, J. M. B., & Bradley, R. K. (2023) · eLife · doi:10.7554/elife.89017 · Cited by 18
“CIITA is induced by IFN-γ and is also conspicuously downregulated in DUX4 - expressing tumors ( Figure 2B ; Glimcher and Kara, 1992 ; Masternak et al., 2000 ; Steimle et al., 1993 ; Steimle et al., 1994 ).”
BackgroundEffect of Arabinoxylane and PSP on Activation of Immune Cells
채수연, 신성해, 배만종, 박미현, 송미경, 황성주, & 이성태 (2004) · Journal of the Korean Society of Food Science and Nutrition · doi:10.3746/jkfn.2004.33.2.278 · Cited by 13
Effect of Crossmatching on Outcome in Organ Transplantation
Wang‐Rodriguez, J., Rearden, A., & Halloran, P. F. (1995) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408369509084688 · Cited by 13
Martin, J. J., Worthington, J., Harris, S., & Martin, S. (2009) · International Journal of Immunogenetics · doi:10.1111/j.1744-313x.2009.00854.x · Cited by 13
Endogenous Interferon-γ Acts Directly on Tumor Cellsin Vivoto Suppress Growth
Doherty, G. M., Tsung, K., McCluskey, B., & Norton, J. A. (1996) · Journal of Surgical Research · doi:10.1006/jsre.1996.0308 · Cited by 13
Altered Th1 Cell Differentiation Programming by CIITA Deficiency
Patel, D. R., Kaplan, M. H., & Chang, C. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.9.5501 · Cited by 14
Welsh, F., Farmery, S., Ramsden, C., Guillou, P., & Reynolds, J. V. (1996) · JPEN - Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607196020005344 · Cited by 15
MHC class II regulation in vivo in the mouse kidney
Sims, T. N., & Halloran, P. F. (1999) · Microbes and Infection · doi:10.1016/s1286-4579(99)00227-0 · Cited by 13
Yun, S. (1997) · International Immunology · doi:10.1093/intimm/9.10.1545 · Cited by 13
Transcriptional regulation of MHC class II genes
Sartoris, S., & Accolla, R. S. (1995) · International Journal of Clinical & Laboratory Research · doi:10.1007/bf02592360 · Cited by 13
“Based on these last results, Steimle et al. [ 91 ] hypothesized that class II gene induction after IFN-y treatment was mediated by activation of the CIITA gene.”
ResultTakeuchi, O., Sims, T. N., Takei, Y., Ramassar, V., Famulski, K. S., & Halloran, P. F. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000094084.18567.cc · Cited by 14
Sreenivasan, S., Heffren, P., Suh, K., Rodnin, M. V., Kosa, E., Fenton, A. W., Ladokhin, A. S., Smith, P. E., Fontes, J. D., & Swint‐Kruse, L. (2024) · Protein Science · doi:10.1002/pro.4863 · Cited by 11
“To test these hypotheses, we chose a transcription factor with different domain arrangements than p53/PPAR ɣ — the class II major histocompatibility complex transactivator protein (CIITA) from vertebrates (Steimle et al., 1993, 1994).”
MethodWang, M., Qiao, Y., Wei, S.-J., Su, Z., & Lu, H. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1388814 · Cited by 14
Ouyang, Y., Zhong, X., Liao, H., Zhu, P., Luo, K., & Zhu, H. (2020) · SLAS DISCOVERY · doi:10.1177/2472555220922475 · Cited by 12
Ma, H., Zhao, L., Jiang, Z., Jiang, Y., Li, F., & Ye, Z. (2014) · Clinical Rheumatology · doi:10.1007/s10067-014-2712-1 · Cited by 12
CD39+ regulatory T cells modulate the immune response to carbamazepine in HLA-B*15:02 carriers
Shen, M., Lim, J. M. E., Chia, C., & Ren, E. C. (2019) · Immunobiology · doi:10.1016/j.imbio.2019.11.003 · Cited by 12
Metadata
- Authors
- Steimle, V., Siegrist, C.-A., Mottet, A., Lisowska-Grospierre, B., & Mach, B.
- Affiliations
- University of Geneva (CH)
- Jeantet Laboratory of Molecular Genetics, Department of Genetics and Microbiology, University of Geneva Medical School, CH-1211 Geneva 4, Switzerland.
- INSERM U132, Hôpital des Enfants Malades, 15015 Paris, France.
- Venue
- Science
- Published
- 1994-07
- Volume
- 265
- Issue
- 5168
- Pages
- 106-109
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2060320549
- Cited by
- 898
- References
- 29
- Citations by year
- 2026: 33 · 2025: 35 · 2024: 39 · 2023: 49 · 2022: 35 · 2021: 32 · 2020: 25 · 2019: 20 · 2018: 22 · 2017: 19 · 2016: 27 · 2015: 21 · 2014: 18 · 2013: 13 · 2012: 29
- FWCI
- 13.51
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- MHC class II expression, interferon-gamma, CIITA, MHC class II deficiency, gene expression regulation, transcriptional activation
- MeSH terms
- Histocompatibility Antigens Class II, Cell Line, Chromosome Mapping, Chromosomes, Human, Pair 16, Fibroblasts, Gene Expression Regulation, Genes, MHC Class II, Humans, Interferon-gamma, Models, Genetic, Nuclear Proteins, RNA, Messenger, Transfection, Tumor Cells, Cultured, Trans-Activators
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.